Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1649549708;49709;49710 chr2:178613800;178613799;178613798chr2:179478527;179478526;179478525
N2AB1485444785;44786;44787 chr2:178613800;178613799;178613798chr2:179478527;179478526;179478525
N2A1392742004;42005;42006 chr2:178613800;178613799;178613798chr2:179478527;179478526;179478525
N2B743022513;22514;22515 chr2:178613800;178613799;178613798chr2:179478527;179478526;179478525
Novex-1755522888;22889;22890 chr2:178613800;178613799;178613798chr2:179478527;179478526;179478525
Novex-2762223089;23090;23091 chr2:178613800;178613799;178613798chr2:179478527;179478526;179478525
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: D
  • RefSeq wild type transcript codon: GAT
  • RefSeq wild type template codon: CTA
  • Domain: Fn3-7
  • Domain position: 46
  • Structural Position: 63
  • Q(SASA): 0.8994
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
D/H rs1424817630 0.647 1.0 N 0.57 0.383 0.344017737713 gnomAD-2.1.1 1.21E-05 None None None None N None 0 8.7E-05 None 0 0 None 0 None 0 0 0
D/H rs1424817630 0.647 1.0 N 0.57 0.383 0.344017737713 gnomAD-4.0.0 4.78123E-06 None None None None N None 0 6.86373E-05 None 0 0 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
D/A 0.2229 likely_benign 0.2094 benign -0.425 Destabilizing 0.955 D 0.464 neutral N 0.476804311 None None N
D/C 0.6629 likely_pathogenic 0.6421 pathogenic -0.125 Destabilizing 1.0 D 0.676 prob.neutral None None None None N
D/E 0.134 likely_benign 0.1263 benign -0.442 Destabilizing 0.989 D 0.423 neutral N 0.446892403 None None N
D/F 0.7721 likely_pathogenic 0.7586 pathogenic -0.302 Destabilizing 1.0 D 0.62 neutral None None None None N
D/G 0.121 likely_benign 0.1333 benign -0.662 Destabilizing 0.053 N 0.355 neutral N 0.430943483 None None N
D/H 0.4219 ambiguous 0.4113 ambiguous -0.291 Destabilizing 1.0 D 0.57 neutral N 0.469108851 None None N
D/I 0.5863 likely_pathogenic 0.5489 ambiguous 0.165 Stabilizing 0.999 D 0.627 neutral None None None None N
D/K 0.3663 ambiguous 0.37 ambiguous -0.109 Destabilizing 0.998 D 0.543 neutral None None None None N
D/L 0.4633 ambiguous 0.4302 ambiguous 0.165 Stabilizing 0.998 D 0.611 neutral None None None None N
D/M 0.6401 likely_pathogenic 0.6072 pathogenic 0.367 Stabilizing 1.0 D 0.651 neutral None None None None N
D/N 0.1038 likely_benign 0.1071 benign -0.346 Destabilizing 0.993 D 0.473 neutral N 0.457794581 None None N
D/P 0.7089 likely_pathogenic 0.6763 pathogenic -0.009 Destabilizing 0.999 D 0.529 neutral None None None None N
D/Q 0.3325 likely_benign 0.3108 benign -0.283 Destabilizing 0.999 D 0.527 neutral None None None None N
D/R 0.4738 ambiguous 0.4698 ambiguous 0.109 Stabilizing 0.998 D 0.567 neutral None None None None N
D/S 0.1423 likely_benign 0.1405 benign -0.498 Destabilizing 0.983 D 0.443 neutral None None None None N
D/T 0.3126 likely_benign 0.2893 benign -0.319 Destabilizing 0.998 D 0.54 neutral None None None None N
D/V 0.3985 ambiguous 0.3674 ambiguous -0.009 Destabilizing 0.997 D 0.607 neutral N 0.480111233 None None N
D/W 0.9163 likely_pathogenic 0.9046 pathogenic -0.169 Destabilizing 1.0 D 0.691 prob.neutral None None None None N
D/Y 0.4136 ambiguous 0.4023 ambiguous -0.086 Destabilizing 1.0 D 0.623 neutral N 0.464171109 None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.